HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer.

AbstractOBJECTIVE:
This study aimed to analyze the autonomic control of heart rate variability (HRV) in subjects receiving chronic l-thyroxine (l-T4) treatment after total thyroidectomy and (131)I therapy for differentiated thyroid carcinoma.
METHODS:
Blood pressure (BP) and sympatho-vagal activity (evaluated by power spectral analysis (PSA) of time-domain parameters of HRV) were studied in clinostatism and after orthostatism in 24 healthy controls, and in 12 patients taking l-T4 (125-200 mug/day) to maintain serum TSH levels at <0.01 muIU/ml. The study of HRV by PSA is a non-invasive method of analyzing sympatho-vagal control of HRV by quantifying high-frequency (HF) (0.15-0.4 Hz) and low-frequency (LF) (0.04-0.15 Hz) powers.
RESULTS:
Patients on L-T4 treatment had undetectable TSH levels, serum free T4 (fT4) above the normal range or at the upper limit in one case, and normal free tri-iodothyronine (fT3) levels. Heart rate and R-R intervals were not different in the two groups, both in clinostatism and in ortostatism. Systolic and mean BP were higher in patients than in controls and were inversely correlated with actual serum fT4 levels. During clinostatism, thyroid patients showed significantly lower LF power (P = 0.035), LF/(LF + HF) (P = 0.008) and LF/HF (P = 0.01) than controls. When patients moved from lying to standing, there was a significantly different decrease in orthostatic LF power (P = 0.001), LF/(LF + HF) (P = 0.044) and LF/HF (P = 0.047) versus controls.
CONCLUSIONS:
Changes in autonomic control of HRV, characterized by decreased sympathetic activity and impaired sympatho-vagal balance with preserved vagal tone, are detectable in patients with hyperthyroxinemia due to suppressive l-T4 therapy and increased systolic and mean, but not diastolic, BP.
AuthorsMassimo Casu, Caterina Cappi, Vittoriana Patrone, Eva Repetto, Massimo Giusti, Francesco Minuto, Giovanni Murialdo
JournalEuropean journal of endocrinology (Eur J Endocrinol) Vol. 152 Issue 6 Pg. 819-24 (Jun 2005) ISSN: 0804-4643 [Print] England
PMID15941920 (Publication Type: Journal Article)
Chemical References
  • Thyrotropin
  • Thyroxine
Topics
  • Adult
  • Aged
  • Blood Pressure (drug effects)
  • Electrocardiography
  • Female
  • Heart Rate (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Statistics, Nonparametric
  • Sympathetic Nervous System (drug effects, physiopathology)
  • Thyroid Neoplasms (blood, physiopathology, surgery)
  • Thyrotropin (blood)
  • Thyroxine (adverse effects, blood, therapeutic use)
  • Vagus Nerve (drug effects, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: